P

Inventor

TOYOFUKU MASASHI

JP21 patents
⚠️ This page may combine multiple inventors who share the name “TOYOFUKU MASASHI”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

TAKEDA PHARMACEUTICALS CO

17 patents
US10654874B2May 19, 2020

Heterocyclic compound and use thereof

TAKEDA PHARMACEUTICALS CO4 citations84
US10053456B2Aug 21, 2018

Cyclopropanamine compound and use thereof

TAKEDA PHARMACEUTICALS CO3 citations84
US9884875B2Feb 6, 2018

Heterocyclic compound and use thereof

TAKEDA PHARMACEUTICALS CO7 citations84
US9718814B2Aug 1, 2017

Cyclopropanamine compound and use thereof

TAKEDA PHARMACEUTICALS CO5 citations84
US9714241B2Jul 25, 2017

Cyclopropanamine compound and use thereof

TAKEDA PHARMACEUTICALS CO5 citations84
US9487511B2Nov 8, 2016

Cyclopropanamine compound and use thereof

TAKEDA PHARMACEUTICALS CO5 citations84
US9751885B2Sep 5, 2017

Cyclopropanamine compound and use thereof

TAKEDA PHARMACEUTICALS CO15 citations83
US9499568B2Nov 22, 2016

Heterocyclic compound and use thereof

TAKEDA PHARMACEUTICALS CO8 citations83
US11279713B2Mar 22, 2022

Heterocyclic compound and use thereof

TAKEDA PHARMACEUTICALS CO1 citations72
US10357484B2Jul 23, 2019

Heterocyclic compound

TAKEDA PHARMACEUTICALS CO2 citations71
US10081624B2Sep 25, 2018

Heterocyclic compound

TAKEDA PHARMACEUTICALS CO5 citations71
US10968213B2Apr 6, 2021

Cyclopropanamine compound and use thereof

TAKEDA PHARMACEUTICALS CO0 citations62
US9493484B2Nov 15, 2016

Heterocyclic compound and use thereof

TAKEDA PHARMACEUTICALS CO2 citations62
US12358879B2Jul 15, 2025

Heterocyclic compound

TAKEDA PHARMACEUTICALS CO0 citations61
US10414761B2Sep 17, 2019

Cyclopropanamine compound and use thereof

TAKEDA PHARMACEUTICALS CO0 citations52
US9920047B2Mar 20, 2018

Cyclopropanamine compound and use thereof

TAKEDA PHARMACEUTICALS CO0 citations52
US10308643B2Jun 4, 2019

Heterocyclic compound

TAKEDA PHARMACEUTICALS CO0 citations40

KORI MASAKUNI

2 patents

TAKEDA PHARMACEUTICAL

2 patents